Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

3 Osteoporosis Therapeutics: Introduction 14

3.1 Disease Overview 14

3.2 Epidemiology 17

3.3 Etiology 18

3.4 Pathophysiology 19

3.5 Signs and Symptoms 21

3.6 Diagnosis 22

3.6.1 Physical Examination 22

3.6.2 Medical History 23

3.6.3 BMD Testing 23

3.6.4 Laboratory Tests 25

3.7 Treatment and Management Options 25

3.8 GlobalData Pipeline Report Guidance 29

4 Osteoporosis Therapeutics: Market Characterization 31

4.1 Osteoporosis Therapeutics Market Size (2005–2010) – Global 31

4.2 Osteoporosis Therapeutics Market Forecast (2010–2018) – Global 32

4.3 Osteoporosis Therapeutics Market Size (2005–2010) – The US 34

4.4 Osteoporosis Therapeutics Market Forecast (2010–2018) – The US 35

4.5 Osteoporosis Therapeutics Market Size (2005–2010) – France 37

4.6 Osteoporosis Therapeutics Market Forecast (2010–2018) – France 38

4.7 Osteoporosis Therapeutics Market Size (2005–2010) – Germany 39

4.8 Osteoporosis Therapeutics Market Forecast (2010–2018) – Germany 40

4.9 Osteoporosis Therapeutics Market Size (2005–2010) – Italy 41

4.10 Osteoporosis Therapeutics Market Forecast (2010–2018) – Italy 42

4.11 Osteoporosis Therapeutics Market Size (2005–2010) – Spain 44

4.12 Osteoporosis Therapeutics Market Forecast (2010–2018) – Spain 45

4.13 Osteoporosis Therapeutics Market Size (2005–2010) – The UK 46

4.14 Osteoporosis Therapeutics Market Forecast (2010–2018) – The UK 47

4.15 Osteoporosis Therapeutics Market Size (2005–2010) – Japan 49

4.16 Osteoporosis Therapeutics Market Forecast (2010–2018) – Japan 50

4.17 Drivers and Barriers for the Osteoporosis Therapeutics Market 51

4.17.1 Drivers
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION ... a new E-CUBE Series ultrasound system. Developed to enhance ... clinical areas, the E-CUBE 15 EX produces superb image ... clinical performance in women,s health, general imaging, and shared ... The latest in the renowned E-CUBE Series, the ...
(Date:7/2/2015)... July 2, 2015   Wilson Therapeutics AB , ... Hans Schikan to its board of directors. The appointment ... Meeting on June 30. "We are delighted ... Jonas Hansson , CEO of Wilson Therapeutics. "Hans ... we look forward to his contributions to the Company." ...
(Date:7/1/2015)... July 1, 2015   Cochlear Limited ... solutions, announced today the US Food and Drug ... Implant with Slim Straight Electrode (CI522). Built on ... close collaboration with the world,s leading surgeons, the ... designed to provide the most discreet appearance for ...
Breaking Medicine Technology:E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3
... FAIRFIELD, N.J., Jan. 28, 2011 The Healthcare ... of the Year" is Freda Lewis-Hall, MD, chief medical ... Dr. Lewis-Hall has held leadership roles in direct ... (Photo: http://photos.prnewswire.com/prnh/20110128/DC38263 ) ...
... 2011 TechniScan (OTC Bulletin Board: TSNI ... and commercialization of an automated 3D breast ultrasound imaging ... will present at RetailInvestorConferences.com. DATE: , February 3rd, ... This will be a live, interactive online event where ...
Cached Medicine Technology:Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association 2Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association 3Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association 4TechniScan to Present Live, Online at RetailInvestorConferences.com on February 3rd 2
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at ... nearly $4 million through five federal grants to study a group of related ... deadly diseases. , The research will be conducted in the Regional Biocontainment ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... healthcare providers, has been retained to lead a national chief operating officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
(Date:7/2/2015)... ... July 02, 2015 , ... Evolved Ayurvedic Discoveries , ... an intention to partner with companies that share a similar mission of providing ... water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic herbs, are now available for ...
(Date:7/2/2015)... ... ... A team of quality control (QC) experts at GE Healthcare, led by ... enhanced workflow. Now, Dr. Dunne’s lab has set a lofty goal: to become the ... network. , Join the team members for a new, free educational webinar ...
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the ... Timing announced the release and publication of their newest offering to complement the ... and Newsletter. , Designed in support of coverage for the full spectrum ...
Breaking Medicine News(10 mins):Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4
... in blood pressure, disease scores , , SUNDAY, March 30 ... electronically, good doctor-patient communication helps reduce the risk of ... study. , The four-year study included rural and urban ... were otherwise healthy. They were divided into two groups, ...
... agent that combines 2 medications , , SUNDAY, March 30 (HealthDay ... to make sense of a trial showing that a drug ... no apparent benefit to people at high risk of heart ... a well-known statin -- simvastatin -- with ezetimibe, which also ...
... In a comparison of anticoagulants and stents for use ... and tirofiban had similar outcomes for some cardiac measures ... received stents that released the drug sirolimus had a ... months than patients who received uncoated stents, according to ...
... restenosis risk and don,t increase mortality probability , , SUNDAY, ... tubing placed in diseased coronary arteries to keep them ... attack patients, new research shows. , In the largest ... -- the drug in question retards the growth of ...
... RN ... Organization, HOUSTON, March 29 ... a stronger voice to speak,out for patients and themselves, a northwest Houston ... bargaining,rights., RNs at Cypress Fairbanks Medical Center Hospital voted 119 to ...
... cancer deaths could be avoided with lifestyle changes, experts ... therapies that could cut cancer deaths in half. , ... recent American Cancer Society report that said as many ... with lifestyle changes, such as quitting smoking, maintaining a ...
Cached Medicine News:Health News:Combining Internet With Office Visits Cut Heart Attack Risks 2Health News:Cholesterol Drug Controversy Continues 2Health News:Cholesterol Drug Controversy Continues 3Health News:Comparison of anticoagulants for angioplasty show similar outcomes 2Health News:Drug-Eluting Stents Safe After Heart Attack 2Health News:First Unionized Hospital in Texas 2Health News:First Unionized Hospital in Texas 3Health News:You May Be the Key to Cancer Prevention 2Health News:You May Be the Key to Cancer Prevention 3
... AT20R places fast and accurate ... fingertips. Utilising standard computer hardware ... environment with new testing and ... easily integrated into a modern ...
... a test capability extending to 80, the ... patient's visual field, allowing peripheral defects that ... to be explored. Practice Management Integration provides ... With the Medmont Studio package the practitioner ...
... SNPstream Genotyping System provides an automated scalable ... over 800,000 SNP genotypes per day. Combined ... flexibility, this enables you to process a ... robust solution designed to deliver your intended ...
Egg-Shaped Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be e...
Medicine Products: